
Globus Medical Inc
NYSE:GMED

Intrinsic Value
The intrinsic value of one
GMED
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 72.1 USD,
Globus Medical Inc
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Globus Medical Inc
Fundamental Analysis

Globus Medical’s heavy reliance on the U.S. spine market exposes it to heightened competitive pressures from entrenched orthopedic giants, which may hamper market share and compress pricing if leading rivals broaden their offerings or engage in aggressive discounting.
Globus Medical’s robust robotics platform, highlighted by the ExcelsiusGPS system, offers a strong differentiator in spine procedures and positions the firm at the forefront of emerging surgical technology trends.

Revenue & Expenses Breakdown
Globus Medical Inc
Balance Sheet Decomposition
Globus Medical Inc
Current Assets | 2.2B |
Cash & Short-Term Investments | 890.1m |
Receivables | 578.3m |
Other Current Assets | 708.9m |
Non-Current Assets | 3.1B |
Long-Term Investments | 66.1m |
PP&E | 612.1m |
Intangibles | 2.2B |
Other Non-Current Assets | 168.8m |
Free Cash Flow Analysis
Globus Medical Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Globus Medical Inc
Revenue
|
2.5B
USD
|
Cost of Revenue
|
-1B
USD
|
Gross Profit
|
1.5B
USD
|
Operating Expenses
|
-1.3B
USD
|
Operating Income
|
219.7m
USD
|
Other Expenses
|
-116.7m
USD
|
Net Income
|
103m
USD
|
GMED Profitability Score
Profitability Due Diligence
Globus Medical Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Globus Medical Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
GMED Solvency Score
Solvency Due Diligence
Globus Medical Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Globus Medical Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GMED Price Targets Summary
Globus Medical Inc
According to Wall Street analysts, the average 1-year price target for
GMED
is 100.04 USD
with a low forecast of 82.82 USD and a high forecast of 120.75 USD.
Dividends
Current shareholder yield for GMED is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
GMED
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 72.1 USD,
Globus Medical Inc
is
hidden
.